Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. 2006

Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
Liver Unit, Hepatic Hemodynamic Laboratory, Institut d'Investigacions Biomediques August Pi i Sunyer, Hospital Clinic, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain.

OBJECTIVE The pathophysiological significance of heme oxygenase-1 up-regulation in portal hypertension is not completely understood. In this study, we determined the role of heme oxygenase-1 on oxidative stress, inflammation, angiogenesis, and splanchnic hemodynamics in rats with portal hypertension induced by partial portal vein ligation. METHODS Rats were treated with the heme oxygenase inhibitor SnMP or vehicle for 7 days. Then, oxidative stress was quantified by superoxide anion production, and inflammatory response was assessed by immunofluorescence. Expression of angiogenesis mediators was determined by western blotting, and the extent of portosystemic collaterals by radioactive microspheres. Hemodynamic studies were performed by flowmetry. RESULTS Oxidative stress was significantly increased in the mesentery of portal hypertensive rats, as compared with sham-operated controls. In portal hypertensive rats, chronic heme oxygenase inhibition (1) potentiated oxidative stress and inflammation, (2) significantly decreased VEGF expression, without modifying the extent of collaterals or the splanchnic neovascularization, and (3) significantly decreased superior mesenteric artery blood flow and portal pressure. CONCLUSIONS This study demonstrates that heme oxygenase plays an important (beneficial) role attenuating oxidative stress and inflammation, but it also plays a detrimental role in stimulating VEGF production, and contributing to the development of hyperdynamic splanchnic circulation in rats with portal hypertension.

UI MeSH Term Description Entries
D006975 Hypertension, Portal Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN. Cruveilhier-Baumgarten Disease,Cruveilhier-Baumgarten Syndrome,Cruveilhier Baumgarten Disease,Cruveilhier Baumgarten Syndrome,Disease, Cruveilhier-Baumgarten,Portal Hypertension,Portal Hypertensions,Syndrome, Cruveilhier-Baumgarten
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008665 Metalloporphyrins Porphyrins which are combined with a metal ion. The metal is bound equally to all four nitrogen atoms of the pyrrole rings. They possess characteristic absorption spectra which can be utilized for identification or quantitative estimation of porphyrins and porphyrin-bound compounds. Metalloporphyrin
D011524 Protoporphyrins Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
August 2007, Biochemical and biophysical research communications,
Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
January 2014, Current pharmaceutical design,
Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
July 2005, Free radical biology & medicine,
Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
July 2006, World journal of gastroenterology,
Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
June 1999, Hepatology (Baltimore, Md.),
Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
August 2009, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
September 2019, International immunopharmacology,
Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
June 2001, Journal of hepatology,
Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
August 2007, The Journal of nutritional biochemistry,
Bernhard Angermayr, and Marc Mejias, and Jorge Gracia-Sancho, and Juan Carlos Garcia-Pagan, and Jaime Bosch, and Mercedes Fernandez
August 2010, American journal of hypertension,
Copied contents to your clipboard!